naproxen has been researched along with Adenocarcinoma in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (57.14) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Biddick, L; Janakiram, NB; Li, Q; Lightfoot, S; Lubet, RA; Madka, V; Miller, MS; Mohammed, A; Rao, CV; Sei, S; Singh, A; Steele, VE; Suen, CS; Zhang, Y | 1 |
| DeCastro, A; Janakiram, NB; Lee, HJ; Paul, S; Rao, CV; Reddy, BS; Simi, B; Smolarek, AK; So, JY; Steele, V; Suh, N; Wang, CX | 1 |
| Andrews, J; Andrews, P; Djakiew, D; Krygier, S | 1 |
| Phillips, TE; Stanley, CM | 1 |
| Koutsos, MI; Qiao, L; Rigas, B; Shiff, SJ | 1 |
| Croxtall, JD; Flower, RJ | 1 |
| Hoffmann, D; Nishikawa, A; Prokopczyk, B; Rivenson, A; Zang, E | 1 |
7 other study(ies) available for naproxen and Adenocarcinoma
| Article | Year |
|---|---|
Intermittent Dosing Regimens of Aspirin and Naproxen Inhibit Azoxymethane-Induced Colon Adenoma Progression to Adenocarcinoma and Invasive Carcinoma.
Topics: Adenocarcinoma; Adenoma; Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Azoxymethane; Carcinogens; Colonic Neoplasms; Dose-Response Relationship, Drug; Male; Naproxen; Neoplasm Invasiveness; Rats; Rats, Wistar | 2019 |
Combination of atorvastatin with sulindac or naproxen profoundly inhibits colonic adenocarcinomas by suppressing the p65/β-catenin/cyclin D1 signaling pathway in rats.
Topics: Adenocarcinoma; Animals; Anti-Inflammatory Agents, Non-Steroidal; Anticholesteremic Agents; Antineoplastic Combined Chemotherapy Protocols; Atorvastatin; Azoxymethane; beta Catenin; Carcinogens; Colonic Neoplasms; Cyclin D1; eIF-2 Kinase; Enzyme-Linked Immunosorbent Assay; Heptanoic Acids; Immunoenzyme Techniques; Interleukin-4; Male; Naproxen; Nitric Oxide Synthase Type II; Pyrroles; Rats; Rats, Inbred F344; Signal Transduction; Sulindac; Tumor Necrosis Factor-alpha | 2011 |
Superior effectiveness of ibuprofen compared with other NSAIDs for reducing the survival of human prostate cancer cells.
Topics: Acetaminophen; Adenocarcinoma; Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cell Division; Humans; Ibuprofen; In Situ Nick-End Labeling; Male; Mice; Naproxen; Nitrobenzenes; Prostatic Neoplasms; Sulfonamides; Tumor Cells, Cultured | 2002 |
Bradykinin modulates mucin secretion but not synthesis from an intestinal goblet cell line.
Topics: Adenocarcinoma; Bradykinin; Colonic Neoplasms; Enzyme-Linked Immunosorbent Assay; Fluorescent Antibody Technique; Glucosamine; Humans; Indomethacin; Mucins; Naproxen; Tumor Cells, Cultured | 1994 |
Nonsteroidal antiinflammatory drugs inhibit the proliferation of colon adenocarcinoma cells: effects on cell cycle and apoptosis.
Topics: Adenocarcinoma; Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Aspirin; CDC2 Protein Kinase; CDC2-CDC28 Kinases; Cell Cycle; Cell Division; Colonic Neoplasms; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinases; DNA, Neoplasm; HT29 Cells; Humans; Indomethacin; Naproxen; Piroxicam; Protein Serine-Threonine Kinases | 1996 |
Lipocortin 1 mediates dexamethasone-induced growth arrest of the A549 lung adenocarcinoma cell line.
Topics: Adenocarcinoma; Aldosterone; Annexins; Antibodies, Monoclonal; Calcium-Binding Proteins; Cell Division; Cell Membrane; Dexamethasone; Dinoprostone; Dose-Response Relationship, Drug; Humans; Hydrocortisone; Indomethacin; Kinetics; Lung Neoplasms; Mifepristone; Naproxen; Phospholipases; Progesterone; Recombinant Proteins | 1992 |
A study of betel quid carcinogenesis--VIII. Carcinogenicity of 3-(methylnitrosamino)propionaldehyde in F344 rats.
Topics: Adenocarcinoma; Animals; Carcinogenicity Tests; Carcinogens; Drug Administration Schedule; Female; Injections, Subcutaneous; Kidney Neoplasms; Liver Neoplasms; Lung Neoplasms; Male; Naproxen; Rats; Rats, Inbred F344; Stomach Neoplasms | 1992 |